1. Home
  2. SLB vs EW Comparison

SLB vs EW Comparison

Compare SLB & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Schlumberger N.V.

SLB

Schlumberger N.V.

HOLD

Current Price

$51.42

Market Cap

53.5B

Sector

Energy

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$78.62

Market Cap

46.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLB
EW
Founded
1926
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5B
46.0B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
SLB
EW
Price
$51.42
$78.62
Analyst Decision
Strong Buy
Buy
Analyst Count
19
21
Target Price
$51.49
$96.47
AVG Volume (30 Days)
20.5M
4.6M
Earning Date
04-24-2026
05-13-2026
Dividend Yield
2.29%
N/A
EPS Growth
N/A
N/A
EPS
2.35
1.67
Revenue
$30,440,000,000.00
$5,439,500,000.00
Revenue This Year
$5.40
$12.43
Revenue Next Year
$4.37
$9.89
P/E Ratio
$21.94
$47.32
Revenue Growth
9.46
N/A
52 Week Low
$31.11
$65.94
52 Week High
$52.40
$87.89

Technical Indicators

Market Signals
Indicator
SLB
EW
Relative Strength Index (RSI) 63.44 43.97
Support Level $48.84 $75.51
Resistance Level $52.40 $80.42
Average True Range (ATR) 1.45 2.42
MACD -0.23 -0.00
Stochastic Oscillator 80.30 44.90

Price Performance

Historical Comparison
SLB
EW

About SLB Schlumberger N.V.

SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by two brothers bearing the same last name. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts roughly $3 billion in digital-related revenue.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: